|
FR2295746A1
(fr)
|
1974-12-23 |
1976-07-23 |
Francaise Coop Pharma |
Nouveaux derives du tryptophane a activite nerveuse centrale renforcee
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
IT1179866B
(it)
|
1984-12-12 |
1987-09-16 |
Rotta Research Lab |
Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono
|
|
US4576750A
(en)
|
1985-04-22 |
1986-03-18 |
Merck & Co., Inc. |
Tryptophan derivative
|
|
US5157110A
(en)
|
1988-08-20 |
1992-10-20 |
The Government Of The United States Of America |
Synthetic, anti-complement protein
|
|
US5122614A
(en)
*
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
IL95942A0
(en)
|
1989-10-13 |
1991-07-18 |
Syntex Inc |
Collagen-containing ophthalmic formulation
|
|
US6395888B1
(en)
|
1996-02-01 |
2002-05-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
|
EP1413587A2
(en)
|
1991-05-03 |
2004-04-28 |
Washington University |
Modified complement system regulator
|
|
US5492135A
(en)
|
1992-09-09 |
1996-02-20 |
Devore; Dale P. |
Collagen modulators for use in photoablation excimer laser keratectomy
|
|
US5482135A
(en)
|
1993-06-29 |
1996-01-09 |
Deere & Company |
Combined hydraulic reservoir and vehicle axle
|
|
WO1995003009A1
(en)
|
1993-07-22 |
1995-02-02 |
Oculex Pharmaceuticals, Inc. |
Method of treatment of macular degeneration
|
|
WO1995003807A1
(en)
|
1993-07-27 |
1995-02-09 |
The University Of Sydney |
Treatment of age-related macular degeneration
|
|
US5470952A
(en)
|
1993-10-20 |
1995-11-28 |
Regeneron Pharmaceuticals, Inc. |
CNTF and IL-6 antagonists
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5776970A
(en)
|
1994-04-28 |
1998-07-07 |
Yeda Research And Development Co. Ltd. |
Tryptophan derivatives as protein tyrosine kinase blockers and their use in the treatment of neoplastic diseases
|
|
IL117645A
(en)
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
|
JPH08280800A
(ja)
|
1995-04-12 |
1996-10-29 |
Nissho Corp |
２液注射用プレフィルドシリンジ
|
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US6129761A
(en)
|
1995-06-07 |
2000-10-10 |
Reprogenesis, Inc. |
Injectable hydrogel compositions
|
|
US6346398B1
(en)
|
1995-10-26 |
2002-02-12 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
|
|
WO1997033603A1
(en)
|
1996-03-13 |
1997-09-18 |
Trustees Of The University Of Pennsylvania |
Novel peptides which inhibit complement activation
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US5843778A
(en)
|
1996-06-14 |
1998-12-01 |
The Johns Hopkins University School Of Medicine |
Use of chimeric vaccinia virus complement control proteins to inhibit complement
|
|
JPH1087700A
(ja)
|
1996-06-17 |
1998-04-07 |
Smithkline Beecham Corp |
Ｃ３ａ受容体およびＣ３ａを用いる治療およびスクリーニング方法
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
US6051698A
(en)
|
1997-06-06 |
2000-04-18 |
Janjic; Nebojsa |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
|
JP2002503223A
(ja)
|
1997-04-11 |
2002-01-29 |
アドバンスト・メディシン・インコーポレイテッド |
複数の活性分子を供与する分子
|
|
WO1998047002A2
(en)
|
1997-04-11 |
1998-10-22 |
Advanced Medicine, Inc. |
Polyvalent presenter combinatorial libraries and their uses
|
|
AUPO755097A0
(en)
|
1997-06-25 |
1997-07-17 |
University Of Queensland, The |
Receptor agonist and antagonist
|
|
US6169057B1
(en)
|
1997-09-04 |
2001-01-02 |
The Regents Of The University Of California |
Use of tryptophan and analogs as plant growth regulators
|
|
WO1999013899A1
(en)
|
1997-09-17 |
1999-03-25 |
Trustees Of The University Of Pennsylvania |
Peptides and peptidomimetics for inhibiting complement activation
|
|
US8088386B2
(en)
|
1998-03-20 |
2012-01-03 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
JPH11197234A
(ja)
|
1998-01-09 |
1999-07-27 |
Koken Co Ltd |
眼科用コラーゲンゲル成形物
|
|
US7112327B2
(en)
|
1998-02-20 |
2006-09-26 |
Tanox, Inc. |
Inhibition of complement activation
|
|
WO1999044625A1
(en)
|
1998-03-03 |
1999-09-10 |
John Hopkins University |
Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation
|
|
EP1067950B1
(en)
|
1998-04-10 |
2008-05-14 |
Mayo Foundation For Medical Education And Research |
Neo-tryptophan
|
|
US6197934B1
(en)
|
1998-05-22 |
2001-03-06 |
Collagenesis, Inc. |
Compound delivery using rapidly dissolving collagen film
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
US7084106B1
(en)
|
1999-01-19 |
2006-08-01 |
University Of Louisville Research Foundation, Inc. |
Application of a viral complement inhibitory protein in the treatment and diagnosis of Alzheimer's Disease
|
|
JP2002536386A
(ja)
|
1999-02-12 |
2002-10-29 |
コラジェネシス インク． |
細胞または治療薬の送達のためのコラーゲンベースの注射システム
|
|
US20020102581A1
(en)
|
1999-02-19 |
2002-08-01 |
Hageman Gregory S. |
Diagnostics and therapeutics for ocular disorders
|
|
US7108982B1
(en)
|
1999-02-19 |
2006-09-19 |
University Of Iowa Research Foundation |
Diagnostics and the therapeutics for macular degeneration
|
|
WO2000071147A1
(en)
|
1999-05-25 |
2000-11-30 |
King Faisal Specialist Hospital And Research Centre |
Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
GB9930659D0
(en)
|
1999-12-24 |
2000-02-16 |
Bio Discovery Ltd |
Inhibitors of complement activation
|
|
US20050020525A1
(en)
|
2002-02-20 |
2005-01-27 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US20050032733A1
(en)
|
2001-05-18 |
2005-02-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)
|
|
US7011952B2
(en)
|
2000-02-22 |
2006-03-14 |
University Of Iowa Research Foundation |
Diagnostics and therapeutics for macular degeneration-related disorders
|
|
PT1309726E
(pt)
|
2000-03-30 |
2010-03-08 |
Whitehead Biomedical Inst |
Mediadores de interferência por rna específicos de sequência de rna
|
|
AU2001261103B2
(en)
|
2000-04-29 |
2007-08-23 |
University Of Iowa Research Foundation |
Diagnostics and therapeutics for macular degeneration-related disorders
|
|
US6692759B1
(en)
|
2000-06-28 |
2004-02-17 |
The Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
WO2002011793A1
(fr)
|
2000-08-08 |
2002-02-14 |
Medical Information Services, Inc. |
Seringue pour preparation de necessaire d'injection, valve coulissante intermediaire pour seringues et preparation de necessaire d'injection
|
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
|
AU2001296594A1
(en)
|
2000-10-10 |
2002-04-22 |
Tanox, Inc. |
Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
|
|
US20040259247A1
(en)
|
2000-12-01 |
2004-12-23 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
EP1372602B1
(en)
|
2001-01-09 |
2007-04-18 |
Microchips, Inc. |
Flexible microchip devices for ophthalmic and other applications
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
US20050054596A1
(en)
|
2001-11-30 |
2005-03-10 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
WO2003039404A2
(en)
|
2001-11-09 |
2003-05-15 |
Eyetech Pharmaceuticals |
Methods for treating ocular neovascular diseases
|
|
JP2005538033A
(ja)
|
2001-12-04 |
2005-12-15 |
ナノスペクトラ バイオサイエンセズ，インク． |
過剰なあるいは不適切な新脈管形成によって特徴付けられる病状の治療
|
|
ATE371680T1
(de)
*
|
2002-01-16 |
2007-09-15 |
Biocompatibles Uk Ltd |
Polymerkonjugate
|
|
US7261876B2
(en)
*
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
|
AUPS160602A0
(en)
|
2002-04-08 |
2002-05-16 |
University Of Queensland, The |
Therapeutic method
|
|
AU2003276131A1
(en)
|
2002-06-18 |
2003-12-31 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
ITMI20021527A1
(it)
|
2002-07-11 |
2004-01-12 |
Consiglio Nazionale Ricerche |
Anticorpi anti componente c5 del complemento e loro uso
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
JP3976635B2
(ja)
|
2002-08-05 |
2007-09-19 |
久光製薬株式会社 |
キット製剤用注射器、注射器型キット製剤用中間摺動弁、及び、注射器型キット製剤、並びにｘ線造影剤キット製剤
|
|
PT1549333E
(pt)
*
|
2002-09-20 |
2012-01-03 |
Univ Pennsylvania |
Análogos de compstatina com actividade melhorada
|
|
AU2003277910A1
(en)
|
2002-09-27 |
2004-04-19 |
Novartis Ag |
Ocular gene therapy
|
|
US7459169B2
(en)
|
2002-10-21 |
2008-12-02 |
Allvivo, Inc. |
Surface coating comprising bioactive compound
|
|
WO2004041160A2
(en)
|
2002-10-30 |
2004-05-21 |
University Of Kentucky Research Foundation |
Methods and animal model for analyzing age-related macular degeneration
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
EP1594541A4
(en)
|
2003-02-21 |
2007-03-28 |
Rikshospitalet Radiumhospitale |
METHOD AND COMPOSITIONS FOR TREATING MECONIUM ASPIRATION SYNDROME
|
|
AU2004216176B2
(en)
|
2003-02-21 |
2008-04-03 |
Genentech, Inc. |
Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
|
|
US20050255144A1
(en)
|
2003-04-09 |
2005-11-17 |
Directcontact Llc |
Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
|
|
US20070116672A1
(en)
|
2003-09-05 |
2007-05-24 |
Kotwal Girish J |
Treatment of rheumatic diseases
|
|
WO2005023866A2
(en)
|
2003-09-10 |
2005-03-17 |
Baxter International Inc. |
Peptides that inhibit complement activation
|
|
ES2432112T3
(es)
|
2004-02-10 |
2013-11-29 |
The Regents Of The University Of Colorado, A Body Corporate |
Inhibición del factor B, de la vía alternativa del complemento y métodos relacionados
|
|
PL3385384T3
(pl)
|
2004-02-12 |
2021-03-08 |
Archemix Llc |
Aptamerowe środki terapeutyczne użyteczne w leczeniu zaburzeń powiązanych z dopełniaczem
|
|
WO2005110374A1
(en)
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US20070142339A1
(en)
|
2004-05-10 |
2007-06-21 |
Novacea, Inc. |
Prevention of arterial restenosis with active vitamin d compounds
|
|
US8840893B2
(en)
|
2004-06-10 |
2014-09-23 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
|
JP2008512350A
(ja)
|
2004-07-01 |
2008-04-24 |
イェール ユニバーシティ |
標的化され、そして高密度で薬物が負荷されるポリマー性物質
|
|
US8043609B2
(en)
|
2004-10-08 |
2011-10-25 |
Potentia Pharmaceuticals, Inc. |
Viral complement control proteins for eye disorders
|
|
WO2006042252A2
(en)
|
2004-10-08 |
2006-04-20 |
Potentia Pharmeceuticals, Inc. |
Viral complement control proteins for eye disorders
|
|
CN102618644A
(zh)
|
2004-11-18 |
2012-08-01 |
耶鲁大学 |
治疗眼病的方法和组合物
|
|
EP2357254A1
(en)
|
2005-02-14 |
2011-08-17 |
University of Iowa Research Foundation |
Methods and reagents for treatment and diagnosis of age-related macular degeneration
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
AU2006223108A1
(en)
|
2005-03-11 |
2006-09-21 |
Potentia Pharmaceuticals, Inc. |
Compositions comprising modulators of G-protein-coupled receptor for treatment of macular degeneration
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
MX351152B
(es)
*
|
2005-10-08 |
2017-10-04 |
Potentia Pharmaceuticals Inc |
Compstatina y analogos de la misma para tratar trastornos oculares.
|
|
US20070134244A1
(en)
|
2005-10-14 |
2007-06-14 |
Alcon, Inc. |
Combination treatment for pathologic ocular angiogenesis
|
|
EP3299027A1
(en)
|
2005-11-04 |
2018-03-28 |
Genentech, Inc. |
Use of complement pathway inhibitors to treat ocular diseases
|
|
ES2390828T3
(es)
|
2005-11-28 |
2012-11-16 |
The Trustees Of The University Of Pennsylvania |
Análogos potentes de la compstatina
|
|
CN101346473A
(zh)
|
2005-12-22 |
2009-01-14 |
爱尔康研究有限公司 |
用于在具有补体因子h的风险变体的患者中预防和治疗年龄相关性黄斑变性的c3-转化酶抑制剂
|
|
US20070196367A1
(en)
|
2006-02-22 |
2007-08-23 |
Valentin Dinu |
Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system
|
|
KR101394768B1
(ko)
|
2006-03-30 |
2014-05-21 |
드라이스 파마슈티컬스 아이엔씨 |
캄토테신-세포 투과 펩티드 결합체 및 이를 포함하는 약학 조성물
|
|
PL2148691T3
(pl)
|
2007-02-05 |
2015-12-31 |
Apellis Pharmaceuticals Inc |
Analogi kompstatyny do stosowania w leczeniu stanów zapalnych układu oddechowego
|
|
KR101508621B1
(ko)
|
2007-02-28 |
2015-04-07 |
세리나 쎄라퓨틱스, 인코포레이티드 |
활성화된 폴리옥사졸린 및 이를 포함하는 조성물
|
|
CN101795695B
(zh)
*
|
2007-07-19 |
2016-01-06 |
阿列克斯塞尔公司 |
作为抗癌剂的自组装的两亲性聚合物
|
|
WO2009015087A2
(en)
*
|
2007-07-20 |
2009-01-29 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for treatment of trauma
|
|
US8088884B2
(en)
|
2007-09-27 |
2012-01-03 |
Serina Therapeutics, Inc. |
Multi-armed forms of activated polyoxazoline and methods of synthesis thereof
|
|
AU2008308657A1
(en)
|
2007-10-02 |
2009-04-09 |
Potentia Pharmaceuticals, Inc. |
Sustained delivery of compstatin analogs from gels
|
|
US8110651B2
(en)
|
2008-01-11 |
2012-02-07 |
Serina Therapeutics, Inc. |
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
|
|
JP2011510750A
(ja)
|
2008-01-29 |
2011-04-07 |
クライマン、ギルバート・エイチ |
薬物送達デバイス、キット及びそれらの方法
|
|
EP2278987A4
(en)
|
2008-03-28 |
2012-08-22 |
Apellis Ag |
MODULATION AND REPLY / IMPROVEMENT OF THE COMPLEMENTARY SYSTEM IN THE TREATMENT OF TRAUMATISM
|
|
JP5642673B2
(ja)
|
2008-07-10 |
2014-12-17 |
セリナ・セラピユーテイツクス・インコーポレーテツド |
不活性末端基を有するポリオキサゾリン類、保護された開始基から調製されるポリオキサゾリン類及び関連化合物
|
|
PL2424557T3
(pl)
|
2009-05-01 |
2018-04-30 |
The Trustees Of The University Of Pennsylvania |
Zmodyfikowana kompstatyna z modyfikacjami szkieletu peptydowego i c-końca
|
|
US9291622B2
(en)
|
2009-05-21 |
2016-03-22 |
Apellis Pharmaceuticals, Inc. |
Complement assays and uses thereof
|
|
US20130041134A1
(en)
*
|
2009-11-05 |
2013-02-14 |
Sangart ,Inc. |
Methods for preparing polyethylene glycol maleimide using n-(2-hydroxyethyl) maleimide as a starting material
|
|
EP2338520A1
(de)
*
|
2009-12-21 |
2011-06-29 |
Ludwig Maximilians Universität |
Konjugat mit Zielfindungsligand und dessen Verwendung
|
|
US8625635B2
(en)
|
2010-04-26 |
2014-01-07 |
Cleversafe, Inc. |
Dispersed storage network frame protocol header
|
|
US9421240B2
(en)
|
2010-06-22 |
2016-08-23 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogs for treatment of neuropathic pain
|
|
US20130324482A1
(en)
|
2010-07-09 |
2013-12-05 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogs for treatment of rhinosinusitis and nasal polyposis
|
|
CA2813049A1
(en)
|
2010-09-23 |
2012-03-29 |
The Trustees Of The University Of Pennsylvania |
Modified compstatin with improved stability and binding properties
|
|
CN103687867B
(zh)
|
2011-05-11 |
2017-02-08 |
阿佩利斯制药公司 |
细胞反应性的、长效的或靶向的坎普他汀类似物及其用途
|
|
CN103796667A
(zh)
|
2011-06-22 |
2014-05-14 |
艾普莱斯制药公司 |
用补体抑制剂治疗慢性障碍的方法
|
|
CN110229216B
(zh)
|
2011-09-07 |
2023-06-16 |
宾夕法尼亚州大学理事会 |
具有改善的药代动力学性质的坎普他汀类肽
|
|
WO2014028861A1
(en)
|
2012-08-17 |
2014-02-20 |
Apellis Pharmaceuticals, Inc. |
Detection of high risk drusen
|
|
ES2879430T3
(es)
|
2012-11-15 |
2021-11-22 |
Apellis Pharmaceuticals Inc |
Análogos de compstatina de acción prolongada y composiciones y métodos relacionados
|
|
WO2014078734A2
(en)
|
2012-11-15 |
2014-05-22 |
Apellis Pharmaceuticals, Inc. |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
|
|
US9512180B2
(en)
|
2012-12-19 |
2016-12-06 |
The Regents Of The University Of California |
Compstatin analogs
|
|
WO2014152391A1
(en)
|
2013-03-15 |
2014-09-25 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
WO2015006915A1
(zh)
|
2013-07-16 |
2015-01-22 |
北京机械设备研究所 |
适用于高层和超高层建筑火灾扑救的消防车
|
|
US9806963B2
(en)
|
2013-10-18 |
2017-10-31 |
Cellco Partnership |
Feature activation on device
|
|
EP3359555B1
(en)
*
|
2015-10-07 |
2023-12-20 |
Apellis Pharmaceuticals, Inc. |
Dosing regimens
|
|
JP2020516607A
(ja)
*
|
2017-04-07 |
2020-06-11 |
アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
投与レジメンならびに関連組成物および方法
|